• Japanese
  • Korean
  • Chinese
Cover Image

Myocardial Ischemia Global Clinical Trials Review, H1, 2012

Abstract

Summary

GlobalData's clinical trial report, "Myocardial Ischemia Global Clinical Trials Review, H1, 2012" provides data on the Myocardial Ischemia clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Myocardial Ischemia. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Myocardial Ischemia. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
  • Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
  • Listings of discontinued trials (suspended, withdrawn and terminated)

Reasons to buy

  • Understand the dynamics of a particular indication in a condensed manner
  • Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
  • Obtain discontinued trial listing for trials across the globe
  • Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies

Keywords

Myocardial Ischemia Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Myocardial Ischemia , Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Introduction
    • Myocardial Ischemia
    • Report Guidance
  • Clinical Trials by Region
  • Clinical Trials by Country
    • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
    • Top Five Countries Contributing to Clinical Trials in Europe
    • Top Countries Contributing to Clinical Trials in North America
    • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
    • Top Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by BRIC Nations
  • Clinical Trials by G7 Nations
  • Clinical Trials in G7 Nations by Trial Status
  • Clinical Trials by E7 Nations
  • Clinical Trials in E7 Nations by Trial Status
  • Clinical Trials by Phase
    • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Unaccomplished Trials of Myocardial Ischemia
  • Subjects Recruited Over a Period of Time
  • Prominent Sponsors
    • Top Companies Participating in Myocardial Ischemia Therapeutics Clinical Trials
  • Prominent Drug Comparison
  • Clinical Trial Profiles
    • Clinical Trial Overview of Top Companies
    • Abbott Laboratories
    • Clinical Trial Overview of Abbott Laboratories
    • Medtronic, Inc.
    • Clinical Trial Overview of Medtronic, Inc.
    • Merck & Co., Inc.
    • Clinical Trial Overview of Merck & Co., Inc.
    • Sanofi
    • Clinical Trial Overview of Sanofi
    • Baxter Healthcare Corporation
    • Clinical Trial Overview of Baxter Healthcare Corporation
    • Gilead Sciences, Inc.
    • Clinical Trial Overview of Gilead Sciences, Inc.
    • InfraReDx, Inc.
    • Clinical Trial Overview of InfraReDx, Inc.
    • Pfizer Inc.
    • Clinical Trial Overview of Pfizer Inc.
    • Medicure Inc.
    • Clinical Trial Overview of Medicure Inc.
    • Cytokinetics, Inc
    • Clinical Trial Overview of Cytokinetics, Inc
    • Mesoblast Limited
    • Clinical Trial Overview of Mesoblast Limited
    • Revance Therapeutics, Inc.
    • Clinical Trial Overview of Revance Therapeutics, Inc.
    • Gardia Medical Ltd.
    • Clinical Trial Overview of Gardia Medical Ltd.
    • Corindus, Inc.
    • Clinical Trial Overview of Corindus, Inc.
    • CardioVascular BioTherapeutics, Inc.
    • Clinical Trial Overview of CardioVascular BioTherapeutics, Inc.
    • Lumen Biomedical, Inc.
    • Clinical Trial Overview of Lumen Biomedical, Inc.
    • Medinol Ltd.
    • Clinical Trial Overview of Medinol Ltd.
    • Biological Signal Processing Ltd.
    • Clinical Trial Overview of Biological Signal Processing Ltd.
    • AngioScore, Inc.
    • Clinical Trial Overview of AngioScore, Inc.
    • St. Jude Medical, Inc.
    • Clinical Trial Overview of St. Jude Medical, Inc.
  • Clinical Trial Overview of Top Universities / Institutes / Hospitals
    • Assistance Publique - Hopitaux de Paris
    • Clinical Trial Overview of Assistance Publique - Hopitaux de Paris
    • The University of Edinburgh
    • Clinical Trial Overview of The University of Edinburgh
    • Seoul National University Hospital
    • Clinical Trial Overview of Seoul National University Hospital
    • Hartford Hospital
    • Clinical Trial Overview of Hartford Hospital
    • Mayo Clinic
    • Clinical Trial Overview of Mayo Clinic
    • Ottawa Hospital Research Institute
    • Clinical Trial Overview of Ottawa Hospital Research Institute
    • Flinders Medical Centre
    • Clinical Trial Overview of Flinders Medical Centre
    • University Hospital Inselspital, Berne
    • Clinical Trial Overview of University Hospital Inselspital, Berne
    • University of California, San Francisco
    • Clinical Trial Overview of University of California, San Francisco
    • Sheba Medical Center
    • Clinical Trial Overview of Sheba Medical Center
    • VU University Medical Center
    • Clinical Trial Overview of VU University Medical Center
    • University of Schleswig-Holstein
    • Clinical Trial Overview of University of Schleswig-Holstein
    • Rambam Health Care Campus
    • Clinical Trial Overview of Rambam Health Care Campus
    • Kantonsspital Luzern
    • Clinical Trial Overview of Kantonsspital Luzern
    • Aarhus University
    • Clinical Trial Overview of Aarhus University
    • Erasmus MC
    • Clinical Trial Overview of Erasmus MC
    • Sapienza University of Rome
    • Clinical Trial Overview of Sapienza University of Rome
    • Herning Hospital
    • Clinical Trial Overview of Herning Hospital
    • Douglas W. Losordo, M.D.
    • Clinical Trial Overview of Douglas W. Losordo, M.D.
    • The Ohio State University
    • Clinical Trial Overview of The Ohio State University
  • Five Key Clinical profiles
  • Appendix
    • Abbreviations
    • Definitions
    • Research Methodology
    • Secondary Research
    • About GlobalData
    • Contact Us
    • Disclaimer
    • Source

List of Tables

  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Zone, 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, BRIC Countries, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, G7 Countries, 2012*
  • Myocardial Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, E7 Countries, 2012*
  • Myocardial Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Phase, 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Terminated Clinical Trials, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Abbott Laboratories, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medtronic, Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Merck & Co., Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sanofi, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Baxter Healthcare Corporation, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gilead Sciences, Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by InfraReDx, Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Pfizer Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medicure Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Cytokinetics, Inc, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mesoblast Limited, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Revance Therapeutics, Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Gardia Medical Ltd., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Corindus, Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by CardioVascular BioTherapeutics, Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Lumen Biomedical, Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Medinol Ltd., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Biological Signal Processing Ltd., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by AngioScore, Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by St. Jude Medical, Inc., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Assistance Publique - Hopitaux de Paris, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The University of Edinburgh, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Seoul National University Hospital, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Hartford Hospital, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Mayo Clinic, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Ottawa Hospital Research Institute, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Flinders Medical Centre, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University Hospital Inselspital, Berne, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of California, San Francisco, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sheba Medical Center, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by VU University Medical Center, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by University of Schleswig-Holstein, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Rambam Health Care Campus, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Kantonsspital Luzern, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Aarhus University, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Erasmus MC, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Sapienza University of Rome, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Herning Hospital, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by Douglas W. Losordo, M.D., 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials Market, Global, Clinical Trials by The Ohio State University, 2012*

List of Figures

  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Zone (%), 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Top Countries, 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Top Countries, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, North America, Top Countries (%), 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Central and South America, Top Countries (%), 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, BRIC Countries (%), 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, G7 Countries (%), 2012*
  • Myocardial Ischemia Therapeutics Market, G7 Countries, Clinical Trials by Trial Status, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, E7 Countries (%), 2012*
  • Myocardial Ischemia Therapeutics Market, E7 Countries, Clinical Trials by Trial Status, 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Phase (%), 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials In Progress by Phase, 2012*
  • Myocardial Ischemia Therapeutics Market, Global, Clinical Trials by Trial Status, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2005-2010
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Key Sponsors, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Top Companies by Phase, 2012*
  • Myocardial Ischemia Therapeutics Clinical Trials, Global, Clinical Trials by Prominent Drugs, 2012*
  • GlobalData Methodology
Show More
Pricing
Get Notified
Email me when related reports are published